Clinverse and Datatrak Announce Strategic Partnership
Clinverse, Inc. has established a strategic partnership with Datatrak.
Clinverse, Inc., has established a strategic partnership with Datatrak. The partnership integrates Clinverse's ClinPay® solution with Datatrak ONE® solution. ClinPay automates the entire financial lifecycle of global clinical trials, while the Datatrak ONE solution allows sponsors and CROs to obtain higher quality data faster. By integrating both systems, sponsors and CROs can:
- Further streamline the payment process
- Reduce workload, time, and related costs
- Trigger payments based on actual data entered into EDC system
You can read the full release here.
Semaglutide Significantly Improves Steatohepatitis, Fibrosis in Phase III MASH Trial
May 2nd 2025Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly semaglutide improved liver histology, metabolic markers, and weight loss in patients with biopsy-confirmed metabolic dysfunction–associated steatohepatitis and stage 2 or 3 fibrosis.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
